Ensure your contract is built to navigate GLP-1s, biosimilars, and 2026 changes.
Navigating pharmacy benefits in 2026 requires balancing complex compliance with rising fiscal pressure. Is your PBM contract truly engineered for alignment? Join clinical expert Alissa Johnson as she sits down with leading fiduciary advocate Ann Lewandowski to tackle the year’s most critical pharmacy trends and the essential tips for spotting misalignment red flags.
In this webinar, you’ll learn:
■ How to spot true fiduciary alignment in your partners
■ Potential risks of missing out on low-cost biosimilars
■ Strategies you can use to manage GLP-1 costs while remaining compliant
Offered Free by: SmithRx
See All Resources from: SmithRx
